RxDoctor Payments Data

Samantha Frazier, DO

Family Medicine · Madison, WVNPI 1982132866

Payments from drug & device makers

$1,376in general payments, 2019–2025

Across 74 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$421
  • Lilly USA, LLC$256
  • AbbVie$165
  • Exact Sciences$135
  • GSK$77
  • Lundbeck LLC$66
  • plus $257 from 10 others

What the payments were for

  • Food & beverage$1,376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,376 in reported general payments places this provider in the 70th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$419
Medicare patients
14
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$42,994
TrulicityDulaglutide21$28,772
EliquisApixaban33$27,846
TivicayDolutegravir Sodium12$27,234
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$25,932
JanuviaSitagliptin Phosphate23$25,197
DescovyEmtricitabine/Tenofov Alafenam11$24,298
FarxigaDapagliflozin Propanediol14$13,692
LinzessLinaclotide14$10,746
VascepaIcosapent Ethyl25$10,619
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$8,187
InvokanaCanagliflozin21$7,533
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$4,620
SymbicortBudesonide/Formoterol Fumarate17$4,010
Novolog FlexpenInsulin Aspart23$3,433

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$421$42,99431 claims
Lilly USA, LLCTrulicity$256$28,77221 claims
PfizerEliquis$58$27,84633 claims
GSKTrelegy Ellipta$77$25,93232 claims
AstraZenecaFarxiga, Symbicort$12$17,70231 claims
AbbVieLinzess$165$10,74614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Madison

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →